Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Smith-Uffen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Patient Education and Counseling|January 4, 2021
Motivations and barriers to pursue cancer genomic testing: A systematic reviewMegan Smith-Uffen, Nicci Bartley, Grace Davies, et al.
Journal of Thoracic Disease|April 14, 2025
When to initiate durvalumab after concurrent chemoradiation in unresectable stage III non-small cell lung cancer?-A commentary on the phase II TORG 1937 (DATE) studyMegan Smith-Uffen, Raman Sambhi, Saurav Verma, et al.
The Oncologist|May 20, 2024
Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapyMegan Smith-Uffen, John Park, Andrew Parsonson, et al.
BMC Biology|May 28, 2026
Investigating substrate specificity in arogenate versus prephenate dehydratasesEmily J Clayton, Megan Smith-Uffen, Travis W Tribble, et al.
Palliative Care and Social Practice|March 24, 2025
A mixed methods pilot study of a serious illness communication training curriculum among medical residentsMegan Smith-Uffen, Shilpa Jyothi Kumar, Oren Levine, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
The Omission of Anthracycline Chemotherapy in Women with Early HER2-Negative Breast Cancer-A Systematic Review and Meta-AnalysisDanilo Giffoni de Mello Morais Mata, Mary-Beth Rush, Megan Smith-Uffen, et al.
Clinical Breast Cancer|March 22, 2026
Reduced Survival Outcomes in Socioeconomically Disadvantaged Women With HER2-Negative Breast Cancer Undergoing Chemotherapy in CanadaDanilo Giffoni M M Mata, Italo Fernandes, Megan Smith-Uffen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Patient Education and Counseling|January 4, 2021
Motivations and barriers to pursue cancer genomic testing: A systematic reviewMegan Smith-Uffen, Nicci Bartley, Grace Davies, et al.
Journal of Thoracic Disease|April 14, 2025
When to initiate durvalumab after concurrent chemoradiation in unresectable stage III non-small cell lung cancer?-A commentary on the phase II TORG 1937 (DATE) studyMegan Smith-Uffen, Raman Sambhi, Saurav Verma, et al.
The Oncologist|May 20, 2024
Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapyMegan Smith-Uffen, John Park, Andrew Parsonson, et al.
BMC Biology|May 28, 2026
Investigating substrate specificity in arogenate versus prephenate dehydratasesEmily J Clayton, Megan Smith-Uffen, Travis W Tribble, et al.
Palliative Care and Social Practice|March 24, 2025
A mixed methods pilot study of a serious illness communication training curriculum among medical residentsMegan Smith-Uffen, Shilpa Jyothi Kumar, Oren Levine, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
The Omission of Anthracycline Chemotherapy in Women with Early HER2-Negative Breast Cancer-A Systematic Review and Meta-AnalysisDanilo Giffoni de Mello Morais Mata, Mary-Beth Rush, Megan Smith-Uffen, et al.
Clinical Breast Cancer|March 22, 2026
Reduced Survival Outcomes in Socioeconomically Disadvantaged Women With HER2-Negative Breast Cancer Undergoing Chemotherapy in CanadaDanilo Giffoni M M Mata, Italo Fernandes, Megan Smith-Uffen, et al.
Pageof 1